Tissue plasminogen activator (tPA)

tPA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tissue plasminogen activator (tPA), covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). [Phase 3]

See pricing